午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Kantian 41 billion acquisition of medtronic China not to sell!
 
Author:中國銘鉉 企劃部  Release Time:2017-8-5 10:18:29  Number Browse:638
 
Medical network on August 4 -, according to Kant's le China on July 31, Kant's music announced that the company has completed the medtronic's patient care, lack of deep vein thrombosis and nutrition business acquisitions, trading at $6.1 billion (41 billion yuan). The company has made a portfolio of acquisitions, including $4.5 billion in new unsecured preferred bonds, own cash and loans under existing credit agreements. 
 
The business covers 23 products across multiple care market, there is no lack of among them a lot of industry leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo - almost all hospitals in the United States in the use of these products. 
 
Once the deal is completed, the acquisition will become part of the Kantian medical department, which estimates that all the consolidation and handover of the transaction will be completed in the next 18 months. 
 
Kant le George Barrett, chairman and chief executive, said the business of medtronic for Kant customers bring more varied assortment of products, also include some product portfolio with music, Kant's self-contained well-known brands, the joy of Kant also complement the current medical products business. 
 
Recently, kantile China was revealed to be selling its distribution in China, with a total sales price of about rmb10bn. According to cypress blue equipment, its distribution business, also includes the distribution business of medical devices. The business should be sold along with its pharmaceutical distribution business. The specific buyer has been exposed as a national drug, China resources and one of the drugs, and has not been publicly available to anyone. 
 
Kant's business in China also includes the medical device business of its subordinate contis, which is not a distribution business but a manufacturer's business. In response to the business, kantile said it would not be sold. 
 
Previous article:The President of sanjia hospital has been found out by the procuring of consumables and equipment procurement rights
Next article:Three inspection and blood department directors were investigated and one person was sentenced
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號